Fundraising FoxAMLo Biosciences
Newcastle upon Tyne, GB · 8 known investors
Find your way into AMLo Biosciences
Sign up to find every way you can get introduced to AMLo Biosciences
- Your email: who you already know at AMLo Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the AMLo Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
AMLo Biosciences develops prognostic and companion diagnostic tests for cancer patients, initially focusing on melanoma and oropharyngeal squamous cell carcinoma. The company translates cancer biomarker research into tests designed to stratify patient risk and optimize treatment allocation.
Founders & leadership
Investors · 8
How we know: the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · funding news · northeastfund.org · Not right? Tell us
Also in the syndicate · 3
Companies House · registry record
View on Companies House ↗- Registered name
- AMLO BIOSCIENCES LIMITED
- Company number
- 11004534
- Status
- Administration
- Company type
- Private limited company
- Incorporated
- 10 Oct 2017
- Registered office
- C/O GRANT THORNTON UK ADVISORY & TAX LLP, 11th Floor Landmark St Peters Square Oxford Street, Manchester, M1 4PB
- Nature of business (SIC)
- 71200 — Technical testing and analysis
- Accounts
- last made up to 30 Nov 2024 · next due 31 Aug 2026
- Confirmation statement
- last made up to 9 Oct 2024 · next due 23 Oct 2025
Current officers · 5
- Marie Beagley Labus — director, appointed 5 Dec 2017
- Penny Emma Lovat — director, appointed 5 Dec 2017
- David Lawrence Macdonald — director, appointed 1 Jun 2021
- Vanessa Jane Meaney — director, appointed 1 Mar 2021
- Sandy Blackadder Primrose — director, appointed 24 Nov 2020
Source: Companies House public register · retrieved 7 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does AMLo Biosciences do?
- AMLo Biosciences develops prognostic and companion diagnostic tests for cancer patients, initially focusing on melanoma and oropharyngeal squamous cell carcinoma. The company translates cancer biomarker research into tests designed to stratify patient risk and optimize treatment allocation.
- Who are AMLo Biosciences's investors?
- AMLo Biosciences's investors include Conduit Connect, Esperante Ventures, Future Planet Capital, Milltrust International Group, Northstar Ventures.
- Where is AMLo Biosciences headquartered?
- AMLo Biosciences is headquartered in Newcastle upon Tyne, GB.